New treatment options for people with blood cancers
16 Minuten
Podcast
Podcaster
Beschreibung
vor 7 Jahren
Jeffrey Pu, MD, PhD, left, and nurse Meghan Lewis Jeffrey Pu, MD,
PhD, left, and nurse Meghan Lewis Patients with blood cancers will
have new treatment options in addition to stem cell transplants now
available at the Upstate Cancer Center. Patients with blood cancers
will have new treatment options in addition to stem cell
transplants now available at the Upstate Cancer Center. Jeffrey Pu,
MD, PhD Jeffrey Pu, MD, PhD, and clinical leader Meghan Lewis,
RN, tell about the addition of allogeneic stem cell
transplants and CAR T-cell therapy. Allogeneic stem cell
transplants use stem cells from donors. T-cells are a type of white
blood cells, and chimeric antigen receptor T-cell therapy is a
process in which the patient's own T-cells are engineered to better
attack cancer cells., and clinical leader Meghan Lewis, RN,
tell about the addition of allogeneic stem cell transplants and CAR
T-cell therapy. Allogeneic stem cell transplants use stem cells
from donors. T-cells are a type of white blood cells, and chimeric
antigen receptor T-cell therapy is a process in which the patient's
own T-cells are engineered to better attack cancer cells.
PhD, left, and nurse Meghan Lewis Patients with blood cancers will
have new treatment options in addition to stem cell transplants now
available at the Upstate Cancer Center. Patients with blood cancers
will have new treatment options in addition to stem cell
transplants now available at the Upstate Cancer Center. Jeffrey Pu,
MD, PhD Jeffrey Pu, MD, PhD, and clinical leader Meghan Lewis,
RN, tell about the addition of allogeneic stem cell
transplants and CAR T-cell therapy. Allogeneic stem cell
transplants use stem cells from donors. T-cells are a type of white
blood cells, and chimeric antigen receptor T-cell therapy is a
process in which the patient's own T-cells are engineered to better
attack cancer cells., and clinical leader Meghan Lewis, RN,
tell about the addition of allogeneic stem cell transplants and CAR
T-cell therapy. Allogeneic stem cell transplants use stem cells
from donors. T-cells are a type of white blood cells, and chimeric
antigen receptor T-cell therapy is a process in which the patient's
own T-cells are engineered to better attack cancer cells.
Weitere Episoden
16 Minuten
vor 5 Jahren
16 Minuten
vor 5 Jahren
In Podcasts werben
Kommentare (0)